Schrödinger

Overview

Schrödinger is a scientific software company that develops a physics-based computational platform for molecular discovery and design. This platform is utilized in pharmaceutical, biotechnology, and materials research to accelerate the discovery and optimization of molecules. The company's mission is to improve human health and quality of life by transforming how therapeutics and materials are discovered.

Key Features

• Physics-based Computational Platform — Provides a foundation for simulating chemical interactions to predict molecular behavior.
• Therapeutics Discovery — Enables the discovery and optimization of molecules for drug development, aiming to reduce risk in the process.
• Materials Science Applications — Supports the discovery, optimization, and formulation of new materials through predictive computational methods.
• Proprietary and Collaborative Pipeline — Advances a portfolio of drug discovery programs, both internal and in partnership, to address unmet medical needs.
• Educational Resources — Offers online certification courses, free learning resources, and software for academic teaching in life sciences and materials science.
• Responsible AI Use — Maintains a formal AI Use Policy to ensure scientific integrity, rigorous governance, and ethical application of AI in discovery.

Who It's For

Schrödinger's platform is designed for scientists and researchers in the pharmaceutical, biotechnology, and materials science industries. It caters to organizations involved in drug discovery and development, as well as those focused on creating and optimizing advanced materials. The educational resources also target students and professionals seeking to enhance their skills in computational chemistry and molecular design.

Notable Strengths

Schrödinger demonstrates a strong commitment to scientific integrity and ethical technology use, particularly with its formal AI Use Policy. The company's 30+ years of innovation and continuous investment in R&D highlight its established expertise in physics-based computational platforms. Its internal drug discovery pipeline, leveraging its own platform, provides a practical validation of its technology's capabilities.